BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38664865)

  • 21. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
    Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
    Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
    Shinohara ET; DeWees T; Perkins SM
    Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults.
    Omer B; Kadan-Lottick NS; Roberts KB; Wang R; Demsky C; Kupfer GM; Cooper D; Seropian S; Ma X
    Br J Haematol; 2012 Sep; 158(5):615-25. PubMed ID: 22775513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up.
    Tringale KR; Casey DL; Niyazov G; Lavery JA; Moskowitz C; Friedman DN; Wolden SL
    Pediatr Blood Cancer; 2022 May; 69(5):e29600. PubMed ID: 35234340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
    J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers.
    Trama A; Vener C; Lasalvia P; Bernasconi A;
    Front Oncol; 2022; 12():823115. PubMed ID: 35280767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Henderson TO; Fowler BW; Hamann HA; Nathan PC; Whitton J; Leisenring WM; Oeffinger KC; Neglia JP; Turcotte LM; Arnold MA; Conces MR; Howell RM; Robison LL; Armstrong GT; Alexander KA
    Cancer; 2022 Jan; 128(2):373-382. PubMed ID: 34606625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years.
    Nikkilä R; Hirvonen E; Haapaniemi A; Tapiovaara L; Pitkäniemi J; Malila N; Mäkitie A
    Acta Oncol; 2023 Oct; 62(10):1322-1330. PubMed ID: 37672344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.
    McDonald A; Dai C; Meng Q; Hageman L; Richman J; Wu J; Francisco L; Ross E; Balas N; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Bhatia R; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
    JAMA Oncol; 2023 Mar; 9(3):376-385. PubMed ID: 36656600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second Malignant Neoplasms in Childhood Cancer Survivors Treated in a Tertiary Paediatric Oncology Centre.
    Lim JW; Yeap FS; Chan YH; Yeoh AE; Quah TC; Tan PL
    Ann Acad Med Singap; 2017 Jan; 46(1):11-19. PubMed ID: 28182813
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-Term Risk of Subsequent Malignant Neoplasms Among Childhood and Adolescent Lymphoma Survivors (1975-2013): A Population-Based Predictive Nomogram.
    Liu J; Zheng Q; Beeraka NM; Zhang X; Li T; Song R; Zhao D; Fan R
    Oncologist; 2023 Sep; 28(9):e765-e773. PubMed ID: 37177980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
    Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
    Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
    Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
    J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
    Bluhm EC; Ronckers C; Hayashi RJ; Neglia JP; Mertens AC; Stovall M; Meadows AT; Mitby PA; Whitton JA; Hammond S; Barker JD; Donaldson SS; Robison LL; Inskip PD
    Blood; 2008 Apr; 111(8):4014-21. PubMed ID: 18258798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database.
    Yin X; Xu A; Huang Z; Fan F; Wang Y; Chen L; Cui G; Hu Y; Sun C
    Transl Oncol; 2021 Jul; 14(7):101106. PubMed ID: 33932917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.
    Constine LS; Tarbell N; Hudson MM; Schwartz C; Fisher SG; Muhs AG; Basu SK; Kun LE; Ng A; Mauch P; Sandhu A; Culakova E; Lyman G; Mendenhall N
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):24-33. PubMed ID: 18722263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.